Mycophenolate Mofetil and Steroid for Treatment of Patients With IgA Nephropathy

Mycophenolate Mofetil and Steroid for Treatment of Patients With IgA Nephropathy

Saved in:

Bibliographic Details
Main Authors:	Jing Miao, Parikshit Duriseti, Yeshwanter Radhakrishnan, Lisa Vaughan, Fernando C. Fervenza, Ladan Zand
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Series:	Kidney International Reports
Subjects:	IgA nephropathy immunosuppression kidney failure mycophenolate mofetil prednisone steroid
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024923015553
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Mycophenolate Mofetil and Clostridium difficile-associated Colitis
by: A. I. Dolgushina, et al.
Published: (2021-12-01)

Therapeutic effects of topical Mycophenolate mofetil on hydroquinone-induced depigmentation in Guinea pigs and mice
by: Yuan Guo, et al.
Published: (2025-12-01)

Efficacy and Long-Term Outcomes of Tacrolimus versus Cyclophosphamide and Mycophenolate Mofetil in the Management of Pediatric IgA Vasculitis Nephritis: A Cohort Study in Single-Center
by: Han Y, et al.
Published: (2025-07-01)

Low-dose rituximab followed by mycophenolate mofetil for steroid-dependent/frequently relapsing nephrotic syndrome in children: a case series
by: Jide Song, et al.
Published: (2025-08-01)

Mycophenolate mofetil versus azathioprine as a first-line treatment for autoimmune hepatitis: a comparative systematic review and meta-analysis
by: Amani M. Ali, et al.
Published: (2025-08-01)

STUDY OF THE EFFICIENCY AND SAFETY OF MYCOPHENOLATE MOFETIL THERAPY IN PATIENTSWITH SYSTEMIC SCLERODERMA
by: O A Koneva, et al.
Published: (2011-08-01)

Comparative efficacy and safety of mycophenolate mofetil and azathioprine in combination with corticosteroids in the treatment of lymphocytic myocarditis
by: R. S. Rud, et al.
Published: (2021-12-01)

Optimization of Xanthan Gum and Sorbitol Levels in the Mycophenolate Mofetil Powder for Oral Suspension
by: Amin Umrani, et al.
Published: (2023-01-01)

Successful Long-Term Treatment of Pediatric Relapsing Idiopathic Optic Neuritis with Mycophenolate Mofetil
by: Shuhei Fujino, et al.
Published: (2025-03-01)

Mycophenolate Mofetil in the Management of Oral Mucocutaneous Diseases: Current Evidence and Future Perspectives
by: Khalid Aljohani, et al.
Published: (2025-05-01)

Mycophenolic acid trough level assessment in patients with lupus nephritis; does it make a difference?
by: Ahmed E. Abdulgalil, et al.
Published: (2025-03-01)

Comparative Study of Mycophenolate Mofetil and Methotrexate in Graft-Versus-Host Disease Prophylaxis in Adult Recipients of Related and Unrelated Allo-HSCT
by: IS Moiseev, et al.
Published: (2018-12-01)

Efficacy of mycophenolate mofetil for the maintenance therapy of anti-AQP4 antibody-positive NMOSD complying with probable sjögren’s disease in a 2-year-old girl: a case report
by: Takeshi Yamamoto, et al.
Published: (2025-07-01)

Analysis on effects of different treatment regimens for patients with IgA nephropathy
by: ZHU Ming-zhi, et al.
Published: (2019-01-01)

Effectiveness of myocarditis therapy depending on the diagnosis approach (with or without myocardial biopsy)
by: O. V. Blagova, et al.
Published: (2021-05-01)

COVID-19 Pneumonia in Patients with Chronic Myocarditis (HBV-Associated with InfarctLike Debute): Specifics of the Diseases Course, the Role of the Basic Therapy (Part II)
by: O. V. Blagova, et al.
Published: (2020-11-01)

Mycophenolate mofetil combined with steroids: New experiences in the treatment of idiopathic retroperitoneal fibrosis
by: Obrenčević Katarina, et al.
Published: (2007-01-01)

Current status of clinical studies of IgA nephropathy with minimal proteinuria
by: SHI Yu-zhen, et al.
Published: (2020-01-01)

Association between tonsillectomy plus steroid pulse therapy and renal outcomes in patients with IgA nephropathy: a retrospective cohort study
by: Ayano Hayashi, et al.
Published: (2025-08-01)

Gene polymorphisms associated with immunosuppressant adverse effects in systemic lupus erythematosus: a narrative review
by: Siva Hamdani, et al.
Published: (2025-06-01)

Predictive value of sub classification of focal segmental glomerular sclerosis in Oxford classification of IgA nephropathy
by: Fang Yu, et al.
Published: (2021-01-01)

Efficiency of late conversion from mycophenolate mofetil to everolimus in kidney graft recipients with posttransplant malignancy
by: I. G. Kim, et al.
Published: (2018-01-01)

Serum IgA/C3 ratio as a diagnostic and prognostic biomarker for IgA nephropathy
by: Anitha Swamy, et al.
Published: (2025-08-01)

IgA Nephropathy in the Elderly
by: Dana V. Rizk, et al.
Published: (2025-08-01)

Management of Cutaneous Lesions in Brunsting–Perry Pemphigoid (Bpp): A Single‐Center Retrospective Cohort Study
by: Shirley P. Parraga, et al.
Published: (2025-06-01)

Clinical characteristics of patients with pulmonary sarcoidosis treated with systemic steroids in Japan
by: Michiru Sawahata, et al.
Published: (2025-05-01)

Personal thoughts of IgA nephropathy and purpura nephritis in children
by: Zhang Hong-wen
Published: (2022-07-01)

Clinical Profile and Outcomes of COVID-19 in Renal Transplant Recipients
by: Mohit Mahajan, et al.
Published: (2021-12-01)

Clinicopathological analysis of IgA nephropathy combined with hyperuricemia
by: CAI Wei-cheng, et al.
Published: (2016-01-01)

Related factors of hyperuricemia in patients with IgA nephropathy
by: Li Yu-feng, et al.
Published: (2021-01-01)

The value of biomarkers in the diagnosis and prognostic analysis of IgA nephropathy
by: Lu Min, et al.
Published: (2025-01-01)

Clinicopathological characteristics and related factors of IgA nephropathy with hyperuricemia
by: Ren Hui-min, et al.
Published: (2021-01-01)

IMMUNOGLOBULIN A (IgA) AND ITS RECEPTORS
by: V. B. Klimovich, et al.
Published: (2014-07-01)

PHARMACOECONOMIC ANALYSIS OF EVEROLIMUS IMMUNOSUPRESSIVE THERAPY AFTER RENAL TRANSPLANTATION
by: M. V. Avxentyeva, et al.
Published: (2015-06-01)

A POSSIBLE RELATIONSHIP BETWEEN SERUM HOMOCYSTEINE LEVEL AND IgA NEPHROPATHY IN CHILDREN
by: Cemile Pehlivanoğlu, et al.
Published: (2021-09-01)

Mycophenolate mofetil and atherosclerosis
by: Z S Alekberova, et al.
Published: (2009-10-01)

A comparative study of pharmacokinetics of coated tablets of mycophenolic acid
by: A. L. Khokhlov, et al.
Published: (2016-11-01)

Carboxymethyl-lysine is a Prominent Target of Circulating IgA in IgA Nephropathy
by: Sara Alibrandi, et al.
Published: (2025-07-01)

Clinical observation on Shenning mixture in treating IgA nephropathy
by: LIU Hong-yan, et al.
Published: (2016-01-01)

Telitacicept as an alternative to non-steroidal immunosuppressive therapies in the treatment of myasthenia gravis: a study on clinical efficacy and steroid-sparing effect
by: Zheyu Fang, et al.
Published: (2025-03-01)